Unfortunately, no universally held SOC is available for recurrent GBM, especially those displaying an unmethylated O6-Methyl-guanine-methyl-transferase (MGMT) promoter and wild-type IDH-1/2 gene status. Here, MGMT is linked to glioblastoma.